At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
LEGN Legend Biotech
Post-Mkt 07-15 18:06:37 EDT
23.04
-2.63
-10.25%
盘后23.16
+0.12+0.52%
17:49 EDT
High25.75Low22.90Vol5.22M
Open25.56D1 Closing25.67Amplitude11.12%
Mkt Cap4.46BTradable Cap2.08BTotal Shares193.44M
T/O123.60MT/O Rate5.79%Tradable Shares90.19M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Analysts Offer Insights on Healthcare Companies: Medicinova (MNOV), Legend Biotech (LEGN) and AngioDynamics (ANGO)
TIPRANKS  ·  00:30
Analysts Offer Insights on Healthcare Companies: Medicinova (MNOV), Legend Biotech (LEGN) and AngioDynamics (ANGO)
Genscript Highlights Strong CARVYKTI Sales via Legend Biotech, Urges Investor Caution
TIPRANKS  ·  07-15 20:38
Genscript Highlights Strong CARVYKTI Sales via Legend Biotech, Urges Investor Caution
Legend Biotech: Carvykti® Generated About $657 Million in Net Trade Sales During Qtr Ended June 30, 2026
THOMSON REUTERS  ·  07-15 19:31
Legend Biotech: Carvykti® Generated About $657 Million in Net Trade Sales During Qtr Ended June 30, 2026
Barclays Sticks to Its Buy Rating for Legend Biotech (LEGN)
TIPRANKS  ·  07-14 16:36
Barclays Sticks to Its Buy Rating for Legend Biotech (LEGN)
Legend Biotech Price Target Announced at $35.00/share by JP Morgan
Dow Jones  ·  07-13 19:12
Legend Biotech Price Target Announced at $35.00/share by JP Morgan
Legend Biotech is Maintained at Outperform by RBC Capital
Dow Jones  ·  07-08
Legend Biotech is Maintained at Outperform by RBC Capital
RBC Capital Adjusts Legend Biotech Price Target to $63 From $64, Maintains Outperform Rating
MT Newswires Live  ·  07-07
RBC Capital Adjusts Legend Biotech Price Target to $63 From $64, Maintains Outperform Rating
Legend Biotech Insider Move: Director Offloads Stake in High-Profile Transaction
TIPRANKS  ·  07-03
Legend Biotech Insider Move: Director Offloads Stake in High-Profile Transaction
Legend Biotech Director Casey Patrick John Disposes of 6,000 Common Shares for $88,800
Reuters  ·  07-03
Legend Biotech Director Casey Patrick John Disposes of 6,000 Common Shares for $88,800
Calidi Biotherapeutics Appoints Former Genentech/Roche and Celgene Executive Corsee Sanders, Ph.d., to Board of Directors
THOMSON REUTERS  ·  06-23
Calidi Biotherapeutics Appoints Former Genentech/Roche and Celgene Executive Corsee Sanders, Ph.d., to Board of Directors
Calidi Biotherapeutics Appoints Former Genentech/Roche and Celgene Executive Corsee Sanders, Ph.D., to Board of Directors
GlobeNewswire  ·  06-23
Calidi Biotherapeutics Appoints Former Genentech/Roche and Celgene Executive Corsee Sanders, Ph.D., to Board of Directors
Legend Biotech Prices $226 Million ADS Offering to Bolster Cell Therapy Expansion
TIPRANKS  ·  06-23
Legend Biotech Prices $226 Million ADS Offering to Bolster Cell Therapy Expansion
Legend Biotech prices 7,700,000 ADS follow-on offering at $29.35 each
Reuters  ·  06-23
Legend Biotech prices 7,700,000 ADS follow-on offering at $29.35 each
Movement Alert｜Legend Biotech Rises 5.44% in Regular Trading, $226 Million ADS Offering Completed Combined with Positive Lymphoma Therapy Data
Market Focus  ·  06-23
Movement Alert｜Legend Biotech Rises 5.44% in Regular Trading, $226 Million ADS Offering Completed Combined with Positive Lymphoma Therapy Data
3 US Growth Stocks With Strong Balance Sheets And Earnings Focus
Simply Wall St.  ·  06-19
3 US Growth Stocks With Strong Balance Sheets And Earnings Focus
Legend Biotech (LEGN) Stock Could Be 51.2% Undervalued After Equity Raise And LB2501 Data
Simply Wall St.  ·  06-19
Legend Biotech (LEGN) Stock Could Be 51.2% Undervalued After Equity Raise And LB2501 Data
Movement Alert｜Legend Biotech Falls 16.02% in Regular Trading, Secondary Offering of $226 Million ADS Priced at Discount
Market Focus  ·  06-19
Movement Alert｜Legend Biotech Falls 16.02% in Regular Trading, Secondary Offering of $226 Million ADS Priced at Discount
BUZZ-U.S. STOCKS ON THE MOVE-Kardigan, Energy companies
Reuters  ·  06-18
BUZZ-U.S. STOCKS ON THE MOVE-Kardigan, Energy companies
Legend Biotech falls -12.2%
TIPRANKS  ·  06-18
Legend Biotech falls -12.2%
BUZZ-U.S. STOCKS ON THE MOVE-Pfizer, Accenture, Kroger
Reuters  ·  06-18
BUZZ-U.S. STOCKS ON THE MOVE-Pfizer, Accenture, Kroger

Introduction

Company Name.
Legend Biotech
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
Legend Biotech Corp is a global, clinical-stage biopharmaceutical company engaged in the discovery and development of novel cell therapies for oncology and other indications. The company's differentiated technology, global development and manufacturing strategy and expertise provide it with the ability to generate, test and manufacture next-generation cell therapies targeting indications with high unmet needs.
Issue price:
--